We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.39B
AUM Growth
+$59.8M
Cap. Flow
-$14.7M
Cap. Flow %
-1.06%
Top 10 Hldgs %
28.57%
Holding
270
New
10
Increased
47
Reduced
134
Closed
6

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$3.11M
2
NEE icon
NextEra Energy
NEE
+$1.43M
3
TJX icon
TJX Companies
TJX
+$1.14M
4
EOG icon
EOG Resources
EOG
+$1.13M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$850K

Top Sells

Rank Stock Value
1
LKQ icon
LKQ Corp
LKQ
+$4.1M
2
AMZN icon
Amazon
AMZN
+$1.77M
3
MSFT icon
Microsoft
MSFT
+$1.72M
4
AAPL icon
Apple
AAPL
+$1.19M
5
DLTR icon
Dollar Tree
DLTR
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 15.77%
3 Industrials 9.54%
4 Financials 9.35%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
251
Unilever
UL
$135B
$205K 0.01%
3,636
-844
-19% -$46.8K
SWK icon
252
Stanley Black & Decker
SWK
$15.4B
$204K 0.01%
2,083
– –
DXCM icon
253
DexCom
DXCM
$33B
$203K 0.01%
+1,462
New +$184K
SLB icon
254
SLB Ltd
SLB
$77.8B
$202K 0.01%
+3,683
New +$186K
VCIT icon
255
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
$202K 0.01%
2,515
– –
FRST icon
256
Primis Financial Corp
FRST
$402M
$179K 0.01%
14,715
-500
-3% -$6.21K
GSAT icon
257
Globalstar
GSAT
$10.9B
$162K 0.01%
7,333
– –
RLAY icon
258
Relay Therapeutics
RLAY
$4.42B
$103K 0.01%
12,397
– –
CYT
259
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$73K 0.01%
24,197
– –
DNA icon
260
Ginkgo Bioworks
DNA
$521M
$26K ﹤0.01%
563
– –
CWT icon
261
California Water Service
CWT
$3.05B
– –
-3,865
Closed -$200K
DOW icon
262
Dow Inc
DOW
$21.8B
– –
-3,916
Closed -$215K
EEM icon
263
iShares MSCI Emerging Markets ETF
EEM
$29.9B
– –
-5,819
Closed -$234K
LKQ icon
264
LKQ Corp
LKQ
$6.21B
– –
-85,841
Closed -$4.1M
NYT icon
265
New York Times
NYT
$10.4B
– –
-4,200
Closed -$206K
SPLK
266
DELISTED
Splunk Inc
SPLK
– –
-3,110
Closed -$474K
VRAY
267
DELISTED
ViewRay, Inc.
VRAY
$0 ﹤0.01%
10,000
– –
7 8 9 10
11

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2024 Portfolio in Review

As of Q1 2024, Boston Family Office held 270 positions worth $1.39B, up 4.5% from $1.33B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Family Office's Q1 2024 filing shows 10 new, 47 increased, 134 reduced and 6 closed positions. Its largest new stake was Palantir: 25,000 shares worth $575K. The largest sale was LKQ Corp, an estimated $4.1M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Family Office's largest Q1 2024 buy was Palantir: 25,000 shares worth $575K.
  • Boston Family Office added most to Palo Alto Networks in Q1 2024, an estimated $3.11M increase.
  • Boston Family Office's biggest Q1 2024 reduction was Amazon, cutting an estimated $1.77M.
  • Boston Family Office fully exited LKQ Corp in Q1 2024, selling an estimated $4.1M.
  • Boston Family Office's ten largest holdings make up 29% of its $1.39B portfolio in Q1 2024.
  • Boston Family Office opened 10 new positions and closed 6 in Q1 2024.
  • Boston Family Office's portfolio value rose 4.5% quarter-over-quarter to $1.39B.

Based on Boston Family Office's 13F filing for Q1 2024, filed 13 May 2024.